| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Family Practice | 15 | 2020 | 312 | 2.580 |
Why?
|
| Cardiovascular Diseases | 9 | 2023 | 940 | 2.190 |
Why?
|
| Internship and Residency | 12 | 2020 | 596 | 2.110 |
Why?
|
| Telemedicine | 7 | 2022 | 700 | 1.890 |
Why?
|
| Cancer Survivors | 2 | 2023 | 146 | 1.350 |
Why?
|
| Telomere | 7 | 2018 | 59 | 1.260 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 1536 | 1.220 |
Why?
|
| Primary Health Care | 13 | 2022 | 703 | 1.220 |
Why?
|
| Physician-Patient Relations | 5 | 2017 | 261 | 1.160 |
Why?
|
| Diabetes Mellitus | 11 | 2008 | 694 | 1.030 |
Why?
|
| Humans | 104 | 2023 | 68618 | 1.010 |
Why?
|
| Quality Improvement | 4 | 2017 | 413 | 1.000 |
Why?
|
| Obesity | 12 | 2018 | 1076 | 0.990 |
Why?
|
| Adult | 62 | 2022 | 21403 | 0.980 |
Why?
|
| Smoking Cessation | 3 | 2022 | 1034 | 0.940 |
Why?
|
| Attitude to Health | 6 | 2013 | 403 | 0.870 |
Why?
|
| Office Visits | 2 | 2020 | 83 | 0.830 |
Why?
|
| Coronary Disease | 4 | 2008 | 358 | 0.800 |
Why?
|
| Minority Groups | 4 | 2021 | 197 | 0.800 |
Why?
|
| Gonorrhea | 1 | 2022 | 50 | 0.790 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2022 | 29 | 0.770 |
Why?
|
| Female | 68 | 2023 | 38074 | 0.770 |
Why?
|
| Male | 67 | 2022 | 37321 | 0.730 |
Why?
|
| Anti-HIV Agents | 1 | 2022 | 135 | 0.710 |
Why?
|
| Social Media | 1 | 2021 | 59 | 0.710 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 454 | 0.710 |
Why?
|
| Health Services Accessibility | 6 | 2021 | 581 | 0.700 |
Why?
|
| Risk Assessment | 8 | 2015 | 2007 | 0.700 |
Why?
|
| Health Status Disparities | 4 | 2013 | 326 | 0.690 |
Why?
|
| Buprenorphine | 1 | 2020 | 67 | 0.680 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 207 | 0.680 |
Why?
|
| Biomedical Research | 3 | 2017 | 310 | 0.670 |
Why?
|
| United States | 36 | 2021 | 7367 | 0.660 |
Why?
|
| Quality of Health Care | 4 | 2020 | 322 | 0.660 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 300 | 0.660 |
Why?
|
| Aspirin | 2 | 2014 | 295 | 0.650 |
Why?
|
| Patient Selection | 5 | 2021 | 592 | 0.650 |
Why?
|
| Health Behavior | 8 | 2018 | 458 | 0.640 |
Why?
|
| Patient Satisfaction | 4 | 2021 | 378 | 0.640 |
Why?
|
| Prostatic Neoplasms | 2 | 2022 | 778 | 0.630 |
Why?
|
| Body Mass Index | 13 | 2018 | 867 | 0.620 |
Why?
|
| Counseling | 2 | 2023 | 280 | 0.610 |
Why?
|
| Internet | 2 | 2018 | 390 | 0.590 |
Why?
|
| Middle Aged | 46 | 2022 | 21147 | 0.590 |
Why?
|
| Quality Indicators, Health Care | 4 | 2020 | 136 | 0.580 |
Why?
|
| Mobile Applications | 5 | 2020 | 138 | 0.580 |
Why?
|
| Leukocytes | 4 | 2018 | 99 | 0.570 |
Why?
|
| Acute Disease | 1 | 2018 | 658 | 0.570 |
Why?
|
| Depression | 5 | 2018 | 943 | 0.560 |
Why?
|
| South Carolina | 15 | 2020 | 2752 | 0.550 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 298 | 0.540 |
Why?
|
| Internationality | 1 | 2016 | 74 | 0.520 |
Why?
|
| Trust | 5 | 2021 | 75 | 0.520 |
Why?
|
| Global Health | 1 | 2016 | 136 | 0.510 |
Why?
|
| Intrauterine Devices | 2 | 2013 | 15 | 0.500 |
Why?
|
| Hypercholesterolemia | 3 | 2007 | 86 | 0.490 |
Why?
|
| Computers, Handheld | 1 | 2015 | 44 | 0.490 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2019 | 468 | 0.490 |
Why?
|
| Surveys and Questionnaires | 9 | 2020 | 2800 | 0.490 |
Why?
|
| Education | 1 | 2015 | 83 | 0.490 |
Why?
|
| Life Style | 5 | 2010 | 338 | 0.490 |
Why?
|
| HIV Infections | 2 | 2022 | 791 | 0.480 |
Why?
|
| Logistic Models | 13 | 2015 | 1420 | 0.480 |
Why?
|
| Nutrition Surveys | 10 | 2012 | 208 | 0.470 |
Why?
|
| Acculturation | 4 | 2008 | 25 | 0.470 |
Why?
|
| Coronary Artery Disease | 5 | 2012 | 696 | 0.470 |
Why?
|
| Hypertension | 7 | 2020 | 1535 | 0.460 |
Why?
|
| Adolescent | 18 | 2021 | 8912 | 0.450 |
Why?
|
| Ferritins | 3 | 2012 | 49 | 0.450 |
Why?
|
| Vitamin D Deficiency | 3 | 2010 | 292 | 0.420 |
Why?
|
| Social Marketing | 1 | 2012 | 33 | 0.410 |
Why?
|
| Lipids | 2 | 2020 | 298 | 0.410 |
Why?
|
| Community Participation | 1 | 2012 | 42 | 0.410 |
Why?
|
| Risk Factors | 16 | 2014 | 5731 | 0.400 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 373 | 0.400 |
Why?
|
| Electronics | 2 | 2022 | 25 | 0.400 |
Why?
|
| Insulin | 5 | 2010 | 619 | 0.390 |
Why?
|
| Cross-Sectional Studies | 14 | 2020 | 2279 | 0.390 |
Why?
|
| Anti-Bacterial Agents | 5 | 2011 | 1026 | 0.390 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 447 | 0.380 |
Why?
|
| Prostate-Specific Antigen | 2 | 2022 | 138 | 0.370 |
Why?
|
| Health Surveys | 9 | 2010 | 489 | 0.370 |
Why?
|
| Stress, Psychological | 2 | 2015 | 824 | 0.370 |
Why?
|
| Genetic Markers | 1 | 2010 | 144 | 0.360 |
Why?
|
| Carrier State | 2 | 2010 | 39 | 0.350 |
Why?
|
| Calcinosis | 2 | 2010 | 241 | 0.340 |
Why?
|
| Exercise | 4 | 2010 | 658 | 0.340 |
Why?
|
| Diet | 3 | 2010 | 514 | 0.330 |
Why?
|
| Research Subjects | 3 | 2018 | 45 | 0.330 |
Why?
|
| Young Adult | 11 | 2018 | 5717 | 0.330 |
Why?
|
| Overweight | 2 | 2011 | 186 | 0.320 |
Why?
|
| Meditation | 2 | 2020 | 33 | 0.320 |
Why?
|
| Prehypertension | 2 | 2020 | 40 | 0.320 |
Why?
|
| Smartphone | 2 | 2020 | 69 | 0.320 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 772 | 0.320 |
Why?
|
| Diabetic Nephropathies | 1 | 2009 | 161 | 0.310 |
Why?
|
| Medical Records | 1 | 2008 | 121 | 0.300 |
Why?
|
| Pregnancy in Adolescence | 1 | 2008 | 33 | 0.300 |
Why?
|
| Body Weight | 2 | 2011 | 554 | 0.300 |
Why?
|
| Health Services Research | 2 | 2007 | 209 | 0.300 |
Why?
|
| Complementary Therapies | 1 | 2008 | 43 | 0.300 |
Why?
|
| Cultural Characteristics | 2 | 2008 | 42 | 0.290 |
Why?
|
| Clinical Competence | 5 | 2017 | 657 | 0.290 |
Why?
|
| Aged | 22 | 2018 | 14862 | 0.290 |
Why?
|
| Prenatal Care | 1 | 2008 | 117 | 0.290 |
Why?
|
| Pilot Projects | 6 | 2022 | 1342 | 0.290 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 258 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 767 | 0.270 |
Why?
|
| Cultural Diversity | 3 | 2018 | 67 | 0.270 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 848 | 0.270 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 90 | 0.270 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 45 | 0.260 |
Why?
|
| Students | 1 | 2008 | 233 | 0.260 |
Why?
|
| Adolescent Behavior | 1 | 2008 | 264 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2012 | 1085 | 0.250 |
Why?
|
| Behavior Therapy | 2 | 2018 | 297 | 0.250 |
Why?
|
| Dietary Carbohydrates | 1 | 2005 | 27 | 0.250 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 175 | 0.250 |
Why?
|
| Weight Loss | 2 | 2011 | 319 | 0.250 |
Why?
|
| Depressive Disorder | 2 | 2019 | 621 | 0.240 |
Why?
|
| Hemochromatosis | 3 | 2013 | 13 | 0.240 |
Why?
|
| Perception | 3 | 2023 | 189 | 0.240 |
Why?
|
| Mortality | 1 | 2005 | 163 | 0.240 |
Why?
|
| Transferrin | 3 | 2013 | 94 | 0.240 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2013 | 504 | 0.230 |
Why?
|
| Accreditation | 2 | 2015 | 72 | 0.230 |
Why?
|
| Population Surveillance | 1 | 2005 | 285 | 0.220 |
Why?
|
| Research Personnel | 2 | 2018 | 83 | 0.220 |
Why?
|
| Models, Educational | 2 | 2015 | 67 | 0.210 |
Why?
|
| Feasibility Studies | 2 | 2022 | 652 | 0.210 |
Why?
|
| Retrospective Studies | 4 | 2020 | 7277 | 0.210 |
Why?
|
| Length of Stay | 4 | 2015 | 780 | 0.200 |
Why?
|
| Insulin Resistance | 3 | 2010 | 241 | 0.200 |
Why?
|
| Homosexuality, Male | 1 | 2022 | 34 | 0.200 |
Why?
|
| Curriculum | 3 | 2016 | 575 | 0.200 |
Why?
|
| Program Evaluation | 2 | 2015 | 502 | 0.200 |
Why?
|
| Diabetes Complications | 4 | 2014 | 249 | 0.200 |
Why?
|
| Preventive Health Services | 1 | 2022 | 86 | 0.190 |
Why?
|
| Ambulatory Care | 2 | 2022 | 340 | 0.190 |
Why?
|
| Universities | 2 | 2016 | 191 | 0.190 |
Why?
|
| Southeastern United States | 1 | 2022 | 281 | 0.190 |
Why?
|
| Self Medication | 3 | 2009 | 25 | 0.180 |
Why?
|
| Sex Factors | 4 | 2018 | 1266 | 0.180 |
Why?
|
| Communication Barriers | 2 | 2019 | 48 | 0.180 |
Why?
|
| Intention | 1 | 2021 | 80 | 0.180 |
Why?
|
| Group Processes | 2 | 2017 | 42 | 0.170 |
Why?
|
| ROC Curve | 4 | 2008 | 392 | 0.170 |
Why?
|
| Social Stigma | 1 | 2020 | 53 | 0.170 |
Why?
|
| Burnout, Professional | 1 | 2020 | 64 | 0.170 |
Why?
|
| Socioeconomic Factors | 6 | 2008 | 955 | 0.170 |
Why?
|
| Physicians, Family | 3 | 2022 | 83 | 0.160 |
Why?
|
| Vaping | 1 | 2021 | 124 | 0.160 |
Why?
|
| Telomere Shortening | 1 | 2018 | 8 | 0.160 |
Why?
|
| Research Design | 2 | 2017 | 729 | 0.160 |
Why?
|
| Medication Adherence | 1 | 2022 | 335 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2007 | 1465 | 0.160 |
Why?
|
| Motivation | 2 | 2020 | 561 | 0.160 |
Why?
|
| Survivors | 1 | 2020 | 256 | 0.150 |
Why?
|
| Exercise Test | 3 | 2008 | 242 | 0.150 |
Why?
|
| Teaching | 2 | 2010 | 169 | 0.150 |
Why?
|
| Language | 1 | 2019 | 120 | 0.150 |
Why?
|
| Nasal Cavity | 2 | 2010 | 62 | 0.150 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 89 | 0.150 |
Why?
|
| Iron Overload | 3 | 2013 | 28 | 0.150 |
Why?
|
| Inservice Training | 1 | 2018 | 68 | 0.150 |
Why?
|
| Hospitalization | 2 | 2015 | 978 | 0.150 |
Why?
|
| Medically Uninsured | 2 | 2015 | 99 | 0.140 |
Why?
|
| Blood Pressure | 3 | 2020 | 1451 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 374 | 0.140 |
Why?
|
| Psychotherapy | 2 | 2017 | 253 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1553 | 0.140 |
Why?
|
| Health Status Indicators | 2 | 2007 | 117 | 0.140 |
Why?
|
| Alcohol Drinking in College | 1 | 2016 | 13 | 0.130 |
Why?
|
| Aging | 3 | 2010 | 911 | 0.130 |
Why?
|
| Athletes | 1 | 2016 | 40 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2008 | 274 | 0.130 |
Why?
|
| Demography | 2 | 2015 | 279 | 0.130 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 546 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2077 | 0.130 |
Why?
|
| Health Care Surveys | 4 | 2013 | 239 | 0.130 |
Why?
|
| Group Structure | 1 | 2015 | 4 | 0.130 |
Why?
|
| Medicaid | 2 | 2015 | 302 | 0.130 |
Why?
|
| Age Factors | 6 | 2018 | 1864 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 711 | 0.130 |
Why?
|
| Cholesterol | 2 | 2006 | 331 | 0.130 |
Why?
|
| Organizational Objectives | 1 | 2015 | 70 | 0.120 |
Why?
|
| Age Distribution | 3 | 2013 | 320 | 0.120 |
Why?
|
| Prognosis | 3 | 2012 | 2093 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 3259 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 4848 | 0.120 |
Why?
|
| Iron | 2 | 2013 | 197 | 0.120 |
Why?
|
| Physicians | 1 | 2017 | 324 | 0.120 |
Why?
|
| Menstruation Disturbances | 1 | 2013 | 3 | 0.120 |
Why?
|
| Contraceptive Agents, Female | 1 | 2013 | 16 | 0.110 |
Why?
|
| Child | 4 | 2010 | 6405 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 24 | 0.110 |
Why?
|
| Hospital Mortality | 2 | 2012 | 384 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2008 | 1054 | 0.110 |
Why?
|
| Behavioral Sciences | 1 | 2013 | 5 | 0.110 |
Why?
|
| Chlamydophila Infections | 1 | 2012 | 6 | 0.110 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2012 | 13 | 0.110 |
Why?
|
| Focus Groups | 3 | 2013 | 247 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 191 | 0.100 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2012 | 64 | 0.100 |
Why?
|
| Interviews as Topic | 4 | 2017 | 392 | 0.100 |
Why?
|
| Pregnancy | 2 | 2008 | 2334 | 0.100 |
Why?
|
| Hospitals, Religious | 1 | 2011 | 4 | 0.100 |
Why?
|
| Hospitals, Proprietary | 1 | 2011 | 4 | 0.100 |
Why?
|
| Health Status | 2 | 2012 | 429 | 0.100 |
Why?
|
| Hospitals, Public | 1 | 2011 | 22 | 0.100 |
Why?
|
| Papillomavirus Vaccines | 1 | 2013 | 93 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2012 | 1330 | 0.100 |
Why?
|
| Adolescent Medicine | 1 | 2011 | 6 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 138 | 0.100 |
Why?
|
| Parity | 1 | 2011 | 71 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2012 | 131 | 0.100 |
Why?
|
| Random Allocation | 1 | 2012 | 442 | 0.090 |
Why?
|
| Program Development | 2 | 2010 | 240 | 0.090 |
Why?
|
| Odds Ratio | 5 | 2012 | 880 | 0.090 |
Why?
|
| England | 2 | 2007 | 64 | 0.090 |
Why?
|
| Marital Status | 1 | 2010 | 65 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 563 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 319 | 0.090 |
Why?
|
| Hospitals | 1 | 2012 | 265 | 0.090 |
Why?
|
| Data Collection | 2 | 2012 | 420 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2012 | 252 | 0.090 |
Why?
|
| Food Labeling | 1 | 2010 | 10 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 194 | 0.090 |
Why?
|
| Drug Utilization | 2 | 2009 | 119 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2011 | 98 | 0.090 |
Why?
|
| Pain | 1 | 2013 | 472 | 0.090 |
Why?
|
| Mass Screening | 4 | 2022 | 843 | 0.090 |
Why?
|
| Prevalence | 4 | 2011 | 1619 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2011 | 163 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 92 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2013 | 369 | 0.080 |
Why?
|
| Medication Errors | 1 | 2010 | 116 | 0.080 |
Why?
|
| Medical Audit | 1 | 2009 | 44 | 0.080 |
Why?
|
| Commerce | 1 | 2009 | 80 | 0.080 |
Why?
|
| Hepatitis B Antibodies | 1 | 2008 | 8 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2012 | 272 | 0.080 |
Why?
|
| Comorbidity | 2 | 2012 | 1426 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 156 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2013 | 617 | 0.080 |
Why?
|
| Hepatitis C Antibodies | 1 | 2008 | 19 | 0.080 |
Why?
|
| Radioimmunoassay | 1 | 2008 | 164 | 0.080 |
Why?
|
| Energy Intake | 2 | 2010 | 123 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 87 | 0.080 |
Why?
|
| Prescription Drugs | 1 | 2009 | 71 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 137 | 0.080 |
Why?
|
| Morbidity | 1 | 2008 | 130 | 0.080 |
Why?
|
| Researcher-Subject Relations | 1 | 2008 | 4 | 0.080 |
Why?
|
| West Virginia | 1 | 2008 | 11 | 0.080 |
Why?
|
| Genetic Research | 1 | 2008 | 16 | 0.080 |
Why?
|
| Maternal Age | 1 | 2008 | 70 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 1 | 2008 | 43 | 0.080 |
Why?
|
| Time Factors | 3 | 2013 | 4655 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 14 | 0.070 |
Why?
|
| Diarrhea | 1 | 2008 | 63 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2008 | 106 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2020 | 214 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 627 | 0.070 |
Why?
|
| Constipation | 1 | 2008 | 32 | 0.070 |
Why?
|
| Alcoholism | 1 | 2016 | 1109 | 0.070 |
Why?
|
| Healthcare Disparities | 3 | 2018 | 378 | 0.070 |
Why?
|
| Social Support | 1 | 2010 | 423 | 0.070 |
Why?
|
| Body Height | 1 | 2007 | 67 | 0.070 |
Why?
|
| Health Education | 1 | 2009 | 279 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 306 | 0.070 |
Why?
|
| Cosmetics | 1 | 2006 | 5 | 0.070 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 29 | 0.070 |
Why?
|
| Nails | 1 | 2006 | 15 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2011 | 7029 | 0.070 |
Why?
|
| Dioxins | 1 | 2006 | 15 | 0.070 |
Why?
|
| DDT | 1 | 2006 | 19 | 0.070 |
Why?
|
| Self-Assessment | 1 | 2007 | 69 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 1 | 2007 | 70 | 0.070 |
Why?
|
| Alcohol Drinking | 2 | 2010 | 805 | 0.070 |
Why?
|
| Oximetry | 1 | 2006 | 29 | 0.070 |
Why?
|
| Biomarkers | 2 | 2010 | 1593 | 0.070 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 442 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 112 | 0.070 |
Why?
|
| Physician Incentive Plans | 1 | 2006 | 6 | 0.070 |
Why?
|
| National Health Programs | 1 | 2006 | 11 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 439 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2006 | 113 | 0.070 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 10 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 161 | 0.070 |
Why?
|
| Disease Management | 1 | 2007 | 248 | 0.070 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 180 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2007 | 2358 | 0.070 |
Why?
|
| Physical Fitness | 1 | 2006 | 117 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 202 | 0.060 |
Why?
|
| Diet Records | 1 | 2005 | 14 | 0.060 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2006 | 147 | 0.060 |
Why?
|
| Quality of Life | 1 | 2013 | 1515 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.060 |
Why?
|
| Glycemic Index | 1 | 2005 | 28 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 138 | 0.060 |
Why?
|
| Referral and Consultation | 2 | 2018 | 383 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 286 | 0.060 |
Why?
|
| Environmental Pollutants | 1 | 2006 | 180 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2006 | 269 | 0.060 |
Why?
|
| Piperazines | 1 | 2006 | 206 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 3705 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 1753 | 0.060 |
Why?
|
| Infant | 2 | 2010 | 2891 | 0.060 |
Why?
|
| Breast Feeding | 1 | 2005 | 159 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 362 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2005 | 222 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 240 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2005 | 714 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2010 | 3187 | 0.050 |
Why?
|
| Health Promotion | 1 | 2006 | 407 | 0.050 |
Why?
|
| Communication | 2 | 2017 | 329 | 0.050 |
Why?
|
| Smoking | 4 | 2012 | 1452 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 445 | 0.050 |
Why?
|
| Patient Participation | 1 | 2022 | 146 | 0.050 |
Why?
|
| Self Report | 1 | 2022 | 371 | 0.040 |
Why?
|
| Patient Health Questionnaire | 1 | 2019 | 9 | 0.040 |
Why?
|
| Spain | 1 | 2019 | 34 | 0.040 |
Why?
|
| Mouth Diseases | 1 | 1998 | 39 | 0.040 |
Why?
|
| Decision Making | 1 | 2022 | 410 | 0.040 |
Why?
|
| Oral Health | 1 | 1998 | 49 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 17 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1046 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 109 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 186 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2019 | 782 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 209 | 0.030 |
Why?
|
| Patient Education as Topic | 2 | 2010 | 425 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 193 | 0.030 |
Why?
|
| Drug Implants | 1 | 2013 | 19 | 0.030 |
Why?
|
| Hair Diseases | 1 | 2013 | 11 | 0.030 |
Why?
|
| Contraception Behavior | 1 | 2013 | 17 | 0.030 |
Why?
|
| Hemochromatosis Protein | 1 | 2013 | 2 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1851 | 0.030 |
Why?
|
| Headache | 1 | 2013 | 68 | 0.030 |
Why?
|
| Minority Health | 1 | 2013 | 14 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| Weight Gain | 1 | 2013 | 135 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2012 | 90 | 0.030 |
Why?
|
| Insurance, Hospitalization | 1 | 2011 | 6 | 0.030 |
Why?
|
| Sample Size | 1 | 2012 | 79 | 0.030 |
Why?
|
| Workload | 1 | 2012 | 103 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 786 | 0.020 |
Why?
|
| Self Concept | 1 | 2011 | 132 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 60 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Pamphlets | 1 | 2009 | 27 | 0.020 |
Why?
|
| Mass Media | 1 | 2009 | 29 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 219 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1038 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 273 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2010 | 180 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 579 | 0.020 |
Why?
|
| Fasting | 1 | 2008 | 75 | 0.020 |
Why?
|
| Guatemala | 1 | 2008 | 9 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 242 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 951 | 0.020 |
Why?
|
| Honduras | 1 | 2008 | 21 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 38 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 114 | 0.020 |
Why?
|
| Professional Practice Location | 1 | 2007 | 19 | 0.020 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 12 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 1213 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2008 | 45 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2007 | 73 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.020 |
Why?
|
| Diabetic Foot | 1 | 2007 | 33 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 2006 | 54 | 0.020 |
Why?
|
| Clinical Nursing Research | 1 | 2006 | 17 | 0.020 |
Why?
|
| Color | 1 | 2006 | 50 | 0.020 |
Why?
|
| Poverty | 1 | 2008 | 219 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 124 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2006 | 70 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2007 | 110 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 621 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2008 | 224 | 0.020 |
Why?
|
| Sildenafil Citrate | 1 | 2006 | 23 | 0.020 |
Why?
|
| Purines | 1 | 2006 | 39 | 0.020 |
Why?
|
| Electroconvulsive Therapy | 1 | 2011 | 402 | 0.020 |
Why?
|
| Sulfones | 1 | 2006 | 45 | 0.020 |
Why?
|
| United Kingdom | 1 | 2006 | 152 | 0.020 |
Why?
|
| Urology | 1 | 2006 | 31 | 0.020 |
Why?
|
| Bias | 1 | 2006 | 148 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 516 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 291 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2006 | 118 | 0.020 |
Why?
|
| Oxygen | 1 | 2006 | 386 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1040 | 0.020 |
Why?
|
| Self Care | 1 | 2007 | 253 | 0.020 |
Why?
|
| Health Policy | 1 | 2006 | 221 | 0.010 |
Why?
|
| Critical Care | 1 | 2006 | 263 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 786 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 622 | 0.010 |
Why?
|